Essayer OR - Gratuit

India's Transformative Leap in Medtech

Bio Spectrum

|

BioSpectrum India Jan 2025

India's medtech and diagnostics sector is poised for a transformative journey in 2025.

India's Transformative Leap in Medtech

The blend of technology, innovation, and a continued growing commitment to accessibility reshapes the healthcare landscape. While the country is tackling challenges like infrastructural gaps and unequal access, it also draws inspiration from global practices in countries like the US, the UK, and Ireland to create a uniquely Indian healthcare solution. The coming year promises a convergence of emerging trends redefining how healthcare is delivered, experienced, and sustained.

AI-driven Diagnostics The application of artificial intelligence (AI) in healthcare has moved beyond experimentation to become a cornerstone of modern diagnostics. Globally, AI has proven its potential to detect diseases with unparalleled precision. For example, in the US, AI-driven systems have achieved an impressive 95 per cent accuracy in early cancer detection, demonstrating its ability to significantly reduce diagnostic errors.

In India, startups are using AI to address complex health challenges like Niramai uses AI for pain-free breast cancer screening and Qure.ai developed a deep learning algorithm to interpret radiology scans in just a few seconds. Ireland, known for its advanced medtech research, has also been pioneering AI applications in diagnostics. One notable example is Ireland's Health Innovation Hub, which facilitates collaborations between healthcare providers and AI startups to develop cutting-edge diagnostic tools. Drawing from such practices, India could foster partnerships between academia, startups, incubators and healthcare institutions to bridge gaps in diagnostic accessibility, particularly in rural regions.

Enhancing healthcare accessibility with POCT

Bio Spectrum

Cette histoire est tirée de l'édition BioSpectrum India Jan 2025 de Bio Spectrum.

Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.

Déjà abonné ?

PLUS D'HISTOIRES DE Bio Spectrum

Bio Spectrum

Bio Spectrum

WHO certifies Suriname malaria-free

Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO).

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Torrent Pharma buys controlling stake in JB Pharma from KKR for Rs 25,689 Cr valuation

Ahmedabad-based Torrent Pharmaceuticals and global investment firm KKR have announced that Torrent has entered into definitive agreements to acquire controlling stake in Mumbai-based J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR at an Equity Valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities.

time to read

1 min

August 2025

Bio Spectrum

Suraksha Diagnostics injects Rs 22 Cr to establish Eastern India's largest genomics lab

Suraksha Diagnostics, one of the leading diagnostics chains in Eastern India, has launched one of the largest and a state-of-theart genomics lab in Eastern India.

time to read

1 min

August 2025

Bio Spectrum

Illumina buys SomaLogic for $425 M to accelerate proteomics business

Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance-based milestones and performance-based royalties.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Kashmik Formulation to expand capacity, eyes Rs 100 Cr revenue in FY26

Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced significant expansion plans aimed at increasing production capacity, strengthening its presence in international markets, and enhancing operational efficiencies through automation.

time to read

1 min

August 2025

Bio Spectrum

WHO highlights risks associated with use of semaglutide medicines

The World Health Organisation (WHO) is alerting healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicinesOzempic, Rybelsus, and Wegovy.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Lamark Biotech secures Rs 6.5 Cr to accelerate development of thermostable insulin

Lamark Biotech, an innovation-led biopharma startup, has raised Rs 6.5 crore in a PreSeries A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Dr Vinayender Tulla, Dr Nita Roy, and Venkataraman KNK, domain experts of IAN's angel investors led the round.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

AstraZeneca invests Rs 166 Cr to expand Global Hub in Bengaluru

AstraZeneca, a global, science-led biopharmaceutical company, has announced the expansion of its state-of-the-art Global Hub in Bengaluru, strengthening its presence in India.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Novo Nordisk launches injectable Semaglutide for weight management in India

Novo Nordisk, a leading global healthcare company headquartered in Denmark with over a 100-year legacy of chronic disease care, has announced the launch of Wegovy (injectable Semaglutide) in India.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Can Policy Reforms & Investments Trigger India's MedTech MAKEOVER?

India's MedTech sector has long been import-dependent. The Centre is now working to change this by positioning the country as an export-oriented manufacturing hub. A series of policies and investments have been introduced to support this shift. Have these made an impact? What steps are necessary to strengthen India's position in the global medical technology (MedTech) landscape? Let's find out.

time to read

12 mins

August 2025

Listen

Translate

Share

-
+

Change font size